NN-1406

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameNN-1406

Drug Alias NamePrandialNNC0143-0406PI-406NN-1406NNC0143-0406 A

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone

Mechanisms of ActionInsulin receptor agonists

TargetsInsulin receptor

Therapy Area/IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovo Nordisk A/S

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNovo Nordisk A/S

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 1Diabetes Mellitus

ATC CodeN/A